Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25173 | 0.88 | — | — | |
| Water SCHEMBL4085909 | 0.84 | TP53 (0.38) | TP53 | |
| SCHEMBL28586071 | 0.84 | — | — | |
| SCHEMBL27682044 | 0.84 | — | — | |
| Hydrogen Peroxide SCHEMBL374975 | 0.84 | TP53 (0.47) | TP53 | |
| Methyl Alcohol SCHEMBL8763775 | 0.84 | TP53 (0.38) | TP53 | |
| Water SCHEMBL18229925 | 0.84 | — | — | |
| Fluoride SCHEMBL4652779 | 0.84 | — | — | |
| Cyclohexanone SCHEMBL5694918 | 0.81 | TRIM24 (0.55) | — | |
| Cyclohexanol SCHEMBL11413016 | 0.81 | TSHR (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8278333-B2 | Crystals of benzoxadiazole derivative | ASTELLAS PHARMA INC. (JP) | 2012-10-02 | — | — | US | disclosed |
| US-20100178432-A1 | Method of Forming Pattern Film, and Pattern Film Forming Apparatus | KONICA MINOLTA HOLDINGS, INC. (JP) | 2010-07-15 | — | — | US | disclosed |
| US-20090203741-A1 | CRYSTALS OF BENZOXADIAZOLE DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2009-08-13 | — | — | US | disclosed |
| EP-2042498-A1 | CRYSTAL OF BENZOXADIAZOLE DERIVATIVE | Astellas Pharma Inc. (JP) | 2009-04-01 | — | — | EP | disclosed |
| US-20050243428-A1 | Optical functional sheet | TAKAHASHI HIROMITSU | 2005-11-03 | — | — | US | disclosed |
| US-6937399-B2 | Optical functional sheet | TORAY INDUSTRIES, INC. (JP) | 2005-08-30 | — | — | US | disclosed |
| US-20040047042-A1 | Optical functional sheet | TORAY INDUSTRIES, INC. (JP) | 2004-03-11 | — | — | US | disclosed |
| EP-1369711-A1 | OPTICAL FUNCTIONAL SHEET | TORAY INDUSTRIES, INC. (JP) | 2003-12-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203741-A1 | CRYSTALS OF BENZOXADIAZOLE DERIVATIVE | LBR, XDH, CYP4B1 | TP53 4755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.